Sanjivani Paranteral Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Ashwani Khemka, was filed 27 Jul 2026.
Sanjivani Paranteral: what insiders have been doing
Sanjivani Paranteral is a listed company. Filings by its managers are published through SEBI (PIT + SAST). Between 10 November 2025 and 10 November 2026, 2 insiders published 4 filings.
Only purchases show up on the open market, 4 purchases in all worth €22k, filed by 2 insiders. The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 2 major shareholders. The largest single trade was a purchase of €22k by Ashwani Khemka, published on 11 June 2026.
The last insider purchase was made public on 27 July 2026, 106 days ago. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (1,985 companies, median 4 filings), a count of 4 filings is typical. Since 2026, the database holds 4 purchases and no sales by insiders of the company.
Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +24.9%Entry ₹144.35 · Close at T+90 ₹180.25
- +22.7%Entry ₹147.40 · Close at T+90 ₹180.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 16,875 shares-MarketSEBI:fb6ebbeeb95cc58f67382c06b138b46ae9596f9bCanonical exit: 25 Oct 2026 (T+90)
- 17,500 shares-MarketSEBI:82e23325c02b74c4d8d38b8e5d00dc1b6f9bfc40Canonical exit: 8 Oct 2026 (T+90)
- 17,500 shares@ ₹140.20100.0% of flowEquity SharesMarket PurchaseSEBI:3ffaa5b28d809d4814461dc6312a49ee87ff53bcCanonical exit: 9 Sept 2026 (T+90)
- 3,640 shares-MarketSEBI:130acade9e5bc8a4bd6ba34184260f5cb4e65e02Canonical exit: 23 Aug 2026 (T+90)
4 of 4 declarations
About Sanjivani Paranteral
Sanjivani Paranteral is a company listed on the XBOM, specializing in the manufacture of pharmaceutical products. It focuses on intravenous solutions and injectable medications.